Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Archil Jaliashvili: Biological Hemoglobin Oxygen Carriers as a Bridge in Emergencies
Aug 28, 2026, 12:03

Archil Jaliashvili: Biological Hemoglobin Oxygen Carriers as a Bridge in Emergencies

Archil Jaliashvili, Co-Chief Executive Officer at GeoBio Pharm, Biotech Executive, Strategic Partner of BHOC and Precision Oxygen Therapeutics, shared a post on LinkedIn:

”Biological Hemoglobin Oxygen Carriers (BHOCs) – a bridge in emergencies

When donor blood is not available or is not an option – and when conventional blood cannot adequately restore oxygen delivery at the tissue level.

This can happen for different reasons:

  • Severe anemia
  • Ischemia
  • Myocardial infarction
  • Stroke and other acute ischemic conditions
  • Cardiac arrest
  • Severe tissue hypoxia despite conventional treatment

The critical question is therefore not simply:

‘How much blood does the patient have’

It is:

‘Is enough oxygen actually reaching the tissues that need it?’

This is where Biological Hemoglobin Oxygen Carriers (BHOCs) could offer a fundamentally different approach.

  • Not replacing blood.
  • Not replacing donors.

But providing an additional way to deliver oxygen when donor red cells are unavailable, unsuitable, delayed-or when own blood alone may not be sufficient to oxygenate organs and tissues.

The objective is simple:

Get oxygen where and when it is needed.

And when time matters, create the time needed for definitive treatment. Time is life.”

Archil Jaliashvili: Biological Hemoglobin Oxygen Carriers as a Bridge in Emergencies

Other posts featuring Archil Jaliashvili on Hemostasis Today.